HIV sequence data have been used to reconstruct molecular transmission networks, 10 approximating the transmission network and reflecting the transmission pathway of the virus between people. Molecular transmission networks represent powerful scientific and clinical tools to study networks through which communicable diseases are transmitted. 11 Recently, HIV molecular transmission networks have been proposed to target antiretroviral therapy, 12 track the spread of the epidemic, 13, 14 model the possible effects on reduction of transmission for different HIV prevention trials 15 and inform real-time public health interventions. 16 A recent study demonstrated that phylogenetic clustering of recent HCV infection in Australia was associated with HIV/HCV co-infection and genotype 1a infection, 17 suggesting that understanding the network through which the virus is transmitted is important for the successful implementation of treatment and prevention strategies. It has also been demonstrated that HCV phylogenetic clustering is associated with the injecting network in people who inject drugs (PWID) 18 and that epidemic contact structure can be inferred from phylogenetic trees. 19 Recent work in HIV demonstrated the correspondence between communities observed in sexual contact networks and phylogenetic transmission clusters. 20 These findings suggest that in the absence of injecting or sexual network data, the construction of a molecular transmission network using HCV sequence data could shed light on the network through which HCV is transmitted.
Modelling of the impact of directly acting antiviral (DAA) therapy to treat HCV has been performed using the injecting network 21 to inform the implementation of treatment and prevention strategies, such as treatment as prevention. 22 Modelling the impact of DAA therapy in a molecular transmission network using HCV sequences may further validate these strategies and provide insights into the effectiveness of treatment as prevention to reduce transmission of HCV among HIVinfected men who have sex with men (MSM).
Here, a partial molecular transmission network was reconstructed for recent HCV using the methodology previously developed for HIV sequence data. The inferred network was used to model the possible impact of treatment of HCV infection using DAAs on reduction of transmission of HCV in the network. 
| MATERIALS AND METHODS

| Study population and design
| Transmission network reconstruction
Hepatitis C virus nucleotide sequences were obtained from the first available sample at the time of HCV detection. Sequences obtained spanned the HCV genome from Core to the beginning of Envelope-2 (Core-E2) nucleotides 347-1750 in H77 reference sequence (GenBank accession no. NC_004102) and were amplified using a method previously described 26 (Methods S1). Sequence curation and alignment was performed using ClustalX 27 and the final sequence fragment analysed was 1221 bp long following the removal of the hypervariable region one (HVR1) due to the extreme genetic variation seen between individuals in this region. 26 Molecular transmission network inference was performed using freely available software HIV-TRACE (www.hivtrace. 
| Network simulations
The impact of treatment of HCV with DAAs was simulated over the molecular transmission network, inferred using a .03 substitutions/ site genetic distance threshold. We explored the effect of targeting DAA therapy at HIV co-infected nodes and DAA therapy provided to random nodes. For each replicate, a node was randomly selected from either the subset of HIV co-infected nodes or from the set of all nodes. If this node belonged to a cluster, a minimum spanning tree for the cluster was constructed using Wilson's algorithm 30 for efficiently sampling from a uniform distribution of possible spanning trees. These trees were always rooted on the sequence with the oldest estimated date of infection. Because this cohort comprised predominantly acutely infected individuals, the spanning tree constructed for each replicate was taken to be the path of HCV transmission.
As infection progressed over the spanning tree, the HCV infection would be eliminated in the target node at a given efficacy (80%, 
| Study outcomes
The primary study outcome was network connectivity, as defined by being connected to at least one other participant in the molecular transmission network, and participants were defined as either unconnected or connected. Participants who were connected in the network were further categorized by the number of connections they had and how many of those connections were inbound or outbound.
To investigate highly connected components of the network, participants were classified as highly connected if they had three or more outbound edges. The secondary outcome was the median number of potential onward transmission events that were prevented by each treatment strategy that was modelled in the network.
| Statistical analyses
Unadjusted logistic regression analysis was used to identify factors associated with being connected in the network. All variables with P<.20
in the unadjusted analysis were considered in the adjusted logistic regression model, using a backwards stepwise approach with factors sequentially eliminated according to the result of a likelihood ratio test. To account for potential unmeasured confounding introduced by the different cohort characteristics, adjusted logistic regression analysis was performed using mixed modelling, with a random intercept for cohort. For all analyses, statistically significant differences were assessed at P<.05; P-values are two-sided. All analyses were performed using STATA software (version 12.1; StataCorp L.P., College Station, TX, USA).
| RESULTS
| Study population
In total, 293 participants were initially included in this study; however, a Core-E2 sequence was obtainable from 81% (n=236) of participants (ATAHC, n=121; HITS-p, n=92; and HITS-c=, n=23). HCV genotype (G) prevalence was as follows: G1a: 38% (n=90), G1b: 5% (n=12), G2a: 1% (n=4), G2b: 5% (n=11), G3a: 48% (n=114), G6a: 1% (n=2) and G6 l 1% (n=3). The characteristics of those with obtainable HCV sequencing (n=236), and characteristics stratified by being connected in the network, are shown in Table 1 . Overall, 41% (n=92) of participants were in prison at sample collection, all of these participants being from the HITS-p cohort. Of the 16% of participants with HIV infection (n=36), all were males from the ATAHC cohort and reported homosexual exposure as a risk factor for HIV acquisition. Of this group, 17% also reported recent (in the last 6 months) injecting drug use (n=6).
| Molecular transmission network composition
A molecular transmission network was constructed (Figure 1 ).
Overall, 21% of participants (n=49) were connected to at least one other individual in the network. Of those connected in the network, 45% (n=22) were connected to only one other individual, 25%
(n=12) were connected to two other individuals, and 12% (n=13) were connected to three or more individuals. The largest number of connections observed for one individual in the network was six connections. The number of outbound edges observed for individuals in the network ranged from zero to six. In the network, 70%
(n=34) of participants had no outbound edges, 22% (n=11) had one outbound edge, and 10% (n=5) were classified as highly connected, having three or more outbound edges. Of the highly connected participants with 3 or more outbound edges, 80% (n=4) were HIV coinfected. There were 18 individual clusters observed in the network ranging in size from two to seven nodes. Of the clusters observed, 61% (n=11) were made of up two connected nodes, 22% (n=4) were made up of three connected nodes, 11% (n=2) were made up of four connected nodes, and one cluster of seven connected nodes was observed. The participant characteristics that made up these clusters display both discrete features and mixed characteristics. For example, three discrete clusters were observed that contained only HCV/HIV co-infected males and three clusters with mixed characteristics were observed that linked males and females from prison with individuals outside prison (Figure 1 ). Six individuals with more than three outbound edges were observed and 80% were HIV coinfected (n=4).
| Factors associated with network connectivity
Several factors were considered for their association with various aspects of connectivity in the network (Table 1 ). In adjusted logistic regression analysis, after adjusting for participant cohort, the only factor that remained independently associated with being connected in the network was HIV/HCV co-infection (Table 1 (Table S2) . Unadjusted logistic regression analysis was carried out to assess factors associated with having 3 or more outbound edges (Table S3) . People with HIV/ HCV co-infection were more likely to have 3 or more outbound edges (OR 5.64; 95% CI 1.09, 29.13).
| Modelling of impact of targeting treatment in the network
Simulations targeting DAA therapy (with 90% efficacy) to HCV/HIV co-infected individuals prevented 2.5 times more onward infections than simulations providing DAA therapy to the same number of random individuals (Table 2) . By curing one HIV co-infected node, an average of .35 follow-on infections were prevented, compared with .14 follow-on infections prevented by curing a random node. Varying the efficacy of DAA therapy (from 80% to 100%) did not have a substantial impact on the observed findings (Table 2) .
T A B L E 1 Characteristics of participants overall and according to being in the network and logistic regression of factors associated with being in the network at ≤.03 substitutions/site cut-off for participants with recently acquired HCV infection Factors with P< .20 in the unadjusted analysis were included in the adjusted model. Only factors in bold remained significant in the adjusted model.
| DISCUSSION
This study characterized a molecular transmission network for partici- 
